Clinical and epidemiological aspects in Timor patients with the Hansen disease
Keywords:
lepromatous leprosy, tuberculoid leprosy, borderline lepromatous leprosy, multibacillary leprosy, Mycobacterium leprae, inability.Abstract
An observational, descriptive and cross-sectional study of 14 patients with leprosy, diagnosed and assisted in the Dermatology Service of "Guido Valadares" National Hospital, in Dili, Timor Lester was carried out from July to December, 2015, with the aim of characterizing them and to describe some clinical and epidemiological aspects of the disease. In the series a higher frequency of patient was obtained in the age group 26 to 35 years and of the male sex, the predominant clinical form was the multibacilar and the time of clinical course of the symptoms up to reaching the diagnosis was shorter than a year. Equally, in most of them acute reactions were presented, mainly of type II or from the erythema leprosy group, and different degrees of inability.
Downloads
Download data is not yet available.
References
1. Organización Mundial de la Salud. Manual de resoluciones y decisiones de la Asamblea Mundial de la Salud y del Consejo Ejecutivo. Ginebra: Organización Mundial de la Salud; 1973 [citado 10/05/2018]. Disponible en: https://apps.who.int/iris/handle/10665/79016
2. World Health Organization. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010). Regional Office for South-New Delhi: WHO; 2006 [citado 10/05/2018]. Disponible en: http://apps.searo.who.int/PDS_DOCS/B0330.pdf
3. World Health Organization, Regional Office for South-East Asia. Enhanced global strategy for further reducing the disease burden due to leprosy (Plan period: 2011-2015). New Delhi: WHO; 2009 [citado 10/05/2018]. Disponible en: http://www.searo.who.int/entity/global_leprosy_programme/documents/enhanced_global_strategy_2011_2015.pdf
4. World Health Organization. WHO Expert Committee on leprosy: eighth report. Geneva: World Health Organization; 2012 [citado 14/05/2018]. Disponible en: https://apps.who.int/iris/handle/10665/75151
5. World Health Organization. Global leprosy: update on the 2012 situation. Weekly Epidemiological Record. 2013; 88(35): 365-80.
6. World Health Organization. Global leprosy update, 2014: need for early case detection. Weekly Epidemiological Record. 2015; 90(36): 461-76.
7. Organización Mundial de la Salud. Estrategia mundial para la lepra 2016–2020. Acelerar la acción hacia un mundo sin lepra. Guía de monitoreo y evaluación. Ginebra: OMS; 2017 [citado 14/05/2018]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/254907/9789290225874-sp.pdf?sequence=11
8. World Health Organization. WHO Expert Committee on Leprosy: seventh report. Geneva: WHO; 1998. (WHO Technical Report Series 874)
9. World Health Organization; Regional Office for South-East Asia. Bangkok Declaration. Towards a leprosy-free world. International Leprosy Summit: Overcoming the remaining challenges, Bangkok, Tailandia, Julio 24 al 26 Del 2013. Delhi: WHO-SEARO; 2013 [citado 10/05/2018]. Disponible en: http://www.searo.who.int/entity/global_leprosy_programme/bangkok_declaration.pdf
10. World Health Organization; Regional Office for South-East Asia. Guidelines for strengthening participation of persons affected by leprosy in leprosy services. Nueva Delhi: WHO-SEARO; 2011 [citado 14/05/2018]. Disponible en: http://www.searo.who.int/entity/global_leprosy_programme/publications/guide_strengthening_participation_persons_affected_2011.pdf
11. World Health Organization. Accelerating work to overcome the global impact of Neglected Tropical Diseases: A roadmap for implementation. Geneva: WHO; 2012 [citado 14/05/2018]. Disponible en: https://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf
12. World Health Organization. Sustaining the drive to overcome the global impact of Neglected tropical diseases. Second WHO report on neglected tropical diseases. Geneva: WHO; 2013.
13. Uniting to combat neglected tropical diseases. London Declaration on Neglected al Tropic Diseases [citado 18/05/2018]. Disponible en: https://unitingtocombatntds.org/wp-content/uploads/2017/11/london_declaration_on_ntds.pdf
14. Organización Mundial de la Salud. Resolución aprobada por la Asamblea General de las Naciones Unidas sobre la base del informe de la Tercera Comisión (A/65/456/Add.2 (Parte II); Eliminación de la discriminación contra las personas afectadas por la lepra y sus familiares. Principios y directrices para la eliminación de la discriminación contra las personas afectadas por la lepra y sus familiares. Nueva York: Naciones Unidas, 2015.
15. Moreira Rios I, Moreno Diaz EN, Sotolongo Castillo A, Rivera Moreira A, Carballea Suárez Y. Enfoque de los factores de riesgo de la lepra con las determinantes sociales de la salud. Rev Cubana Hig Epidemiol. 2014 [citado 14/05/2018]; 52(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032014000100002
16. Oramas Fernández DK, Cruzata Rodríguez L, Sotto Vargas JD, Poulot Limonta S. Comportamiento de la lepra en dos policlínicos del municipio La Lisa. Rev Cubana Med Gen Integr. 2009 [citado 20/05/2018]; 25(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252009000400008
17. Urbina Torrija JR, García Salazar MP, Letón Pastor MM, Ruiz Pérez R. Epidemiologia de la lepra a través del estudio de la frecuentación en el hospital especializado de trillo durante el período 1943-1995. Rev Esp Salud Pública. 1997 [citado 20/05/2018]; 71(5): 463-77. Disponible en: http://scielo.isciii.es/pdf/resp/v71n5/lepra.pdf
18. Fauci AS, Braunwald E, Isselbacher KJ. Lepra (Enfermedad de Hansen). En: Harrison. Principios de Medicina Interna. 19 ed. Madrid: McGraw-Hill Interamericana; 2015. p. 1162-7.
2. World Health Organization. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010). Regional Office for South-New Delhi: WHO; 2006 [citado 10/05/2018]. Disponible en: http://apps.searo.who.int/PDS_DOCS/B0330.pdf
3. World Health Organization, Regional Office for South-East Asia. Enhanced global strategy for further reducing the disease burden due to leprosy (Plan period: 2011-2015). New Delhi: WHO; 2009 [citado 10/05/2018]. Disponible en: http://www.searo.who.int/entity/global_leprosy_programme/documents/enhanced_global_strategy_2011_2015.pdf
4. World Health Organization. WHO Expert Committee on leprosy: eighth report. Geneva: World Health Organization; 2012 [citado 14/05/2018]. Disponible en: https://apps.who.int/iris/handle/10665/75151
5. World Health Organization. Global leprosy: update on the 2012 situation. Weekly Epidemiological Record. 2013; 88(35): 365-80.
6. World Health Organization. Global leprosy update, 2014: need for early case detection. Weekly Epidemiological Record. 2015; 90(36): 461-76.
7. Organización Mundial de la Salud. Estrategia mundial para la lepra 2016–2020. Acelerar la acción hacia un mundo sin lepra. Guía de monitoreo y evaluación. Ginebra: OMS; 2017 [citado 14/05/2018]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/254907/9789290225874-sp.pdf?sequence=11
8. World Health Organization. WHO Expert Committee on Leprosy: seventh report. Geneva: WHO; 1998. (WHO Technical Report Series 874)
9. World Health Organization; Regional Office for South-East Asia. Bangkok Declaration. Towards a leprosy-free world. International Leprosy Summit: Overcoming the remaining challenges, Bangkok, Tailandia, Julio 24 al 26 Del 2013. Delhi: WHO-SEARO; 2013 [citado 10/05/2018]. Disponible en: http://www.searo.who.int/entity/global_leprosy_programme/bangkok_declaration.pdf
10. World Health Organization; Regional Office for South-East Asia. Guidelines for strengthening participation of persons affected by leprosy in leprosy services. Nueva Delhi: WHO-SEARO; 2011 [citado 14/05/2018]. Disponible en: http://www.searo.who.int/entity/global_leprosy_programme/publications/guide_strengthening_participation_persons_affected_2011.pdf
11. World Health Organization. Accelerating work to overcome the global impact of Neglected Tropical Diseases: A roadmap for implementation. Geneva: WHO; 2012 [citado 14/05/2018]. Disponible en: https://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf
12. World Health Organization. Sustaining the drive to overcome the global impact of Neglected tropical diseases. Second WHO report on neglected tropical diseases. Geneva: WHO; 2013.
13. Uniting to combat neglected tropical diseases. London Declaration on Neglected al Tropic Diseases [citado 18/05/2018]. Disponible en: https://unitingtocombatntds.org/wp-content/uploads/2017/11/london_declaration_on_ntds.pdf
14. Organización Mundial de la Salud. Resolución aprobada por la Asamblea General de las Naciones Unidas sobre la base del informe de la Tercera Comisión (A/65/456/Add.2 (Parte II); Eliminación de la discriminación contra las personas afectadas por la lepra y sus familiares. Principios y directrices para la eliminación de la discriminación contra las personas afectadas por la lepra y sus familiares. Nueva York: Naciones Unidas, 2015.
15. Moreira Rios I, Moreno Diaz EN, Sotolongo Castillo A, Rivera Moreira A, Carballea Suárez Y. Enfoque de los factores de riesgo de la lepra con las determinantes sociales de la salud. Rev Cubana Hig Epidemiol. 2014 [citado 14/05/2018]; 52(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032014000100002
16. Oramas Fernández DK, Cruzata Rodríguez L, Sotto Vargas JD, Poulot Limonta S. Comportamiento de la lepra en dos policlínicos del municipio La Lisa. Rev Cubana Med Gen Integr. 2009 [citado 20/05/2018]; 25(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252009000400008
17. Urbina Torrija JR, García Salazar MP, Letón Pastor MM, Ruiz Pérez R. Epidemiologia de la lepra a través del estudio de la frecuentación en el hospital especializado de trillo durante el período 1943-1995. Rev Esp Salud Pública. 1997 [citado 20/05/2018]; 71(5): 463-77. Disponible en: http://scielo.isciii.es/pdf/resp/v71n5/lepra.pdf
18. Fauci AS, Braunwald E, Isselbacher KJ. Lepra (Enfermedad de Hansen). En: Harrison. Principios de Medicina Interna. 19 ed. Madrid: McGraw-Hill Interamericana; 2015. p. 1162-7.
Published
2019-02-11
How to Cite
1.
Tablada Robinet ME, Marrero Rodríguez H, López Pupo N, Mulén Tablada D, Pérez González O. Clinical and epidemiological aspects in Timor patients with the Hansen disease. MEDISAN [Internet]. 2019 Feb. 11 [cited 2025 Jun. 2];23(1). Available from: https://medisan.sld.cu/index.php/san/article/view/1706
Issue
Section
Original Articles
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
